NASDAQ: VOR
Vor Biopharma Inc Earnings Dates, Reports, Calls

Vor Biopharma earnings were -$2.4B for the trailing 12 months ending Sep 30, 2025, with N/A growth year over year. The latest VOR earnings report on Sep 30, 2025 announced Q3 2025 earnings of -$812.7M, down 48.4% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, VOR reported annual earnings of -$116.9M, with -0.8% growth.

VOR earnings history

Current Revenue
$0.0
Current Earnings
-$2.4B
Current Profit Margin
0%

VOR Return on Equity

Current Company
N/A
Current Industry
-21.3%
Current Market
35.2%

VOR undefined

Current Company
-1,545.9%
Current Industry
-8.8%
VOR is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when VOR announces earnings.

VOR undefined

Current Company
-1,556.28%
Current Industry
-3.4%
VOR's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

VOR vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
VOR-$2.44B-$2.45BN/A-$386.63
CGENN/A-$27.62MN/A-$0.30
CGTX-$27.74M-$27.99MN/A-$0.48
PLX$8.87M$5.39M-29.29%$0.07
GANX-$18.01M-$19.39MN/A-$0.61

Vor Biopharma Earnings Reports & History FAQ

What were Vor Biopharma's earnings last quarter?

On VOR's earnings call on Invalid Date, Vor Biopharma (NASDAQ: VOR) reported Q3 2025 earnings per share (EPS) of -$121.63, up 1,410.93% year over year. Total VOR earnings for the quarter were -$812.68 million. In the same quarter last year, Vor Biopharma's earnings per share (EPS) was -$8.05.

If you're new to stock investing, here's how to buy Vor Biopharma stock.

Is Vor Biopharma profitable or losing money?

As of the last Vor Biopharma earnings report, Vor Biopharma is currently losing money. Vor Biopharma's net profit (also called net income) for the twelve months ending Sep 30, 2025 was -$2.45 billion, a 2,078.1% increase year over year.

What was VOR's earnings growth in the past year?

As of Vor Biopharma's earnings date in Invalid Date, Vor Biopharma's earnings has grown year over year. VOR earnings in the past year totalled -$2.45 billion.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.